November 21, 2009 – The first randomized intracardiac arrest cooling study performed using a intra-nasal cooling method showed promising results. Findings included much faster and earlier cooling in treated patients and significantly higher neurologically intact survival to discharge rate in many patients.

November 21, 2009 — A drug used to treat erectile dysfunction may improve heart function in children and young adults with single ventricle congenital heart disease, according to researchers from The Children’s Hospital of Philadelphia.

November 21, 2009 – The Food and Drug Administration (FDA) recently announced that it is reviewing data from a study suggesting patients using the drug sibutramine may have a higher number of cardiovascular events than patients using a placebo.

November 29, 2009 - A new advanced visualization and decision support software upgrade is designed to improve management of CT stroke protocols and 3D or 2D viewing. It also provides electronic medical record (EMR) integration.

November 24, 2009 - Seventy million dollars in grant money will go to community college training programs for health information technology professionals, and $10 million is designated to develop educational materials to support these programs.

November 24, 2009 – European CE mark clearance was granted this week for BridgePoint Medical’s coronary and peripheral chronic total occlusion (CTO) crossing system comprised of the CrossBoss CTO Crossing Catheter and the Stingray CTO Re-Entry System.

November 24, 2009 - The academic and research communities can access free 2D/3D Windows-based software for reviewing imaging data from CT, MR, PET, ultrasound and X-ray.

November 24, 2009 – New imaging client-server technology is designed to create efficiency and ease of use from any location. With an unlimited number of installed clients, there can be 3/10/20 concurrent users, depending on server hardware configuration and system load.

November 23, 2009 – Using less lytic drug and offering faster clot dissolution than traditional deep vein thrombosis (DVT) treatments, EKOS Corp. launched the EkoSonic MACH4e at the recent VEITH Symposium in New York.

November 23, 2009 – The U.S. Food and Drug Administration (FDA) Nov. 20 approved Revatio (sildenafil) Injection, an intravenous formulation of Revatio, for the treatment of adult patients with pulmonary arterial hypertension (WHO Group I) to improve exercise ability and delay clinical worsening.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now